Bone Biologics' Corporate Minority - P2P Round

Bone Biologics raised a round of funding on March 29, 2018. Investors include Orthofix International.

Bone Biologics (OTCQB:BBLG) was founded to pursue regenerative medicine for bone. The company is building on research on the Nell-1 molecule that has produced a significant number of studies and publi…

Articles about Bone Biologics' Corporate Minority - P2P Round: